Merck Snags Yet Another Indication for This Drug Combo
The company's blockbuster cancer drug Keytruda was approved in Japan to treat patients with certain types of endometrial cancer.
The company's blockbuster cancer drug Keytruda was approved in Japan to treat patients with certain types of endometrial cancer.